A family screening of CD19 gene mutation by PCR-RFLP

Skrócona strona pozycji
dc.contributor.authorKaraselek, Mehmet Ali
dc.contributor.authorKapaklı, Hasan
dc.contributor.authorGüner, Şükrü Nail
dc.contributor.authorKurar, Ercan
dc.contributor.authorKüççüktürk, Serkan
dc.contributor.authorKeleş, Sevgi
dc.contributor.authorReisli, İsmail
dc.date.accessioned2022-07-01T09:12:08Z
dc.date.available2022-07-01T09:12:08Z
dc.date.issued2022
dc.description.abstractIntroduction and aim. Mutation(s) in the gene encoding the CD19 molecule affect CD19 protein expression and primary immunodeficiency (PID) occurs. The PCR-RFLP method, which is faster and cheaper than other mutation detection methods, is rarely used in the diagnosis of PID. The study aimed to genetically identify CD19 deficiency, which is a PID, using the PCR-RFLP method. Material and methods. A total of 8 patients and two healthy controls were included in the study and the relevant region genotypes in the CD19 gene were determined by performing PCR-RFLP analysis. Results. The index case, newborn baby and mother were also included in the study. It was determined that the index case (P6) was homozygous mutant, the newborn baby (P7) and mother (P8) had heterozygous genotype. Based on this situation, one child (P1) was found to be homozygous mutant, mother (P2), father (P3) and other children (P4 and P5) had heterozygous genotype in the family, which was determined to be related to the first case. Conclusion. In our study, it has been shown that PCR-RFLP is a method that can be used in the diagnosis of PID by determining genotypes using PCR-RFLP, and especially in terms of rapid genetic testing of family screenings.pl_PL.UTF-8
dc.description.sponsorshipWe are grateful to all individuals participating in this study. We would like to thank to Necmettin Erbakan University Scientific Research Projects Coordinator for supporting this study with 182018008 research project numbers.pl_PL.UTF-8
dc.identifier.citationEuropean Journal of Clinical and Experimental Medicine T. 20, z. 2 (2022), s. 141–145pl_PL.UTF-8
dc.identifier.doi10.15584/ejcem.2022.2.1
dc.identifier.eissn2544-1361
dc.identifier.urihttp://repozytorium.ur.edu.pl/handle/item/8069
dc.language.isoengpl_PL.UTF-8
dc.publisherWydawnictwo Uniwersytetu Rzeszowskiegopl_PL.UTF-8
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Międzynarodowe*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectCD19pl_PL.UTF-8
dc.subjectPIDpl_PL.UTF-8
dc.subjectRFLPpl_PL.UTF-8
dc.titleA family screening of CD19 gene mutation by PCR-RFLPpl_PL.UTF-8
dc.typearticlepl_PL.UTF-8
Pliki
Oryginalny pakiet
Aktualnie wyświetlane 1 - 1 z 1
Obrazek miniatury
Nazwa:
1 karaselek-a family.pdf
Rozmiar:
536.45 KB
Format:
Adobe Portable Document Format
Opis:
Pobierz
Pakiet licencji
Aktualnie wyświetlane 1 - 1 z 1
Obrazek miniatury
Nazwa:
license.txt
Rozmiar:
1.22 KB
Format:
Item-specific license agreed upon to submission
Opis:
Pobierz
Kolekcje
European Journal of Clinical and Experimental Medicine T.20, z. 2 (2022)